These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 22549447)
1. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes. Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447 [TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma. Krajnović M; Radojković M; Davidović R; Dimitrijević B; Krtolica K Med Oncol; 2013 Mar; 30(1):441. PubMed ID: 23275143 [TBL] [Abstract][Full Text] [Related]
4. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients. Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404 [TBL] [Abstract][Full Text] [Related]
5. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213 [TBL] [Abstract][Full Text] [Related]
6. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells]. Meng CF; Zhu XJ; Dai DQ; Peng G Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579 [TBL] [Abstract][Full Text] [Related]
8. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer. Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO Digestion; 2006; 74(2):85-90. PubMed ID: 17139167 [TBL] [Abstract][Full Text] [Related]
9. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
11. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958 [TBL] [Abstract][Full Text] [Related]
12. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Iliopoulos D; Oikonomou P; Messinis I; Tsezou A Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL. Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513 [TBL] [Abstract][Full Text] [Related]
14. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445 [TBL] [Abstract][Full Text] [Related]
15. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer. Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684 [TBL] [Abstract][Full Text] [Related]
16. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa. Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187 [TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma. Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480 [TBL] [Abstract][Full Text] [Related]
18. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of p16 and MGMT promotes the anti-proliferative and pro-apoptotic effects of 5-Aza-dC and radiation on cervical cancer cells. Chen GD; Qian DY; Li ZG; Fan GY; You KL; Wu YL Cell Biochem Funct; 2017 Dec; 35(8):488-496. PubMed ID: 29143344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]